During its 2020 results presentation, Italian API producer Olon announced the completion of a large-scale, multi-purpose, high-containment HPAPI production line at its Rodano site near Milan. This is already available to customers, the firm added.
Merck KGaA is to spend €59 million to expand HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin. Completion is expected by mid-2022 and should add approximately 50 full-time jobs from 2021.
The investment will allow large-scale manufacturing of highly potent oncology compounds, the company said. The 6,500 m2 building will be one of the largest dedicated HPAPI facilities specifically designed to handle single-digit nanogram OEL materials.
President Emmanuel Macron (above) and Bruno Lemaire, Minister of the Economy, Finance & Recovery, were both present on 28 August, when pharmaceutical CDMO Seqens unveiled a new HPAPI unit at its site in Villeneuve-La-Garenne, France. The total investment in the UPP30 project, as it is called, was about €30 million.